Divi's Labs jumped over 4 per cent on positive outcome of FDA inspection. The stock jumped as much as 4.1 per cent to Rs 1,213, its biggest daily percentage gain since March 27.
On Wednesday, the company had said its unit at Choutuppal in Telangana has undergone successful inspection by the US Food and Drug Administration from May 14-16, without any observations. The unit is engaged in active pharmaceutical ingredients and intermediates for generics. Apart from this, Divi’s Laboratories has a facility in Visakhapatnam.
Up to Wednesday's close, the stock had risen 6.1 per cent compared to Nifty Pharma index's 12.7 per cent fall.
(With inputs from Reuters)